Literature DB >> 26036525

Intravenous superoxide dismutase administration reduces contralateral lung injury induced by unilateral lung ischemia and reperfusion in rats through suppression of activity and protein expression of matrix metalloproteases.

D Y-W Yeh1, S-P Tung2, Y H Fu3, Y C Yang3, J J Wang4.   

Abstract

BACKGROUND: Ischemia and reperfusion (I/R) of the lungs induces massive superoxide radical production. On the other hand, matrix metalloproteases (MMPs) were shown to play an essential role in I/R-associated lung injury. We aimed to investigate the lung-protective efficacy of intravenous superoxide dismutase (SOD) administration and its relation with MMPs activity in the lungs subsequent to I/R injury.
METHODS: Twenty-two male Sprague-Dawley rats were divided into a sham group (n = 6), a unilateral lung I/R group (n = 8), and a SOD-treated lung I/R group (n = 8). Unilateral lung ischemia was conducted by occluding the left lung hilum for 90 min, followed by 5 hours of reperfusion through release of the occlusion. In the SOD-treated group, SOD was administered intravenously during the first hour of reperfusion. We assessed the protein contents in the broncho-alveolar lavage fluid (PCBAL) as a marker for protein permeability and lung wet-to-dry weight ratio (W/D) for lung water content. We also measured levels of lipid peroxidation and MMP activity in the lungs, by tissue malonedealdehyde (MDA) level with the use of enzyme-linked immunoassay, and the gelatin zymography technique, respectively.
RESULTS: Forty-eight hours of left-lung I/R significantly increased PCBAL (P < .001), W/D (P < .05), tissue MDA level (P < .05), and MMP-9 and MMP-2 activity. SOD treatment attenuated I/R-induced contralateral lung injury, reducing pulmonary permeability, lipid peroxidation, and MMP activities.
CONCLUSIONS: I/R injury of the left lung induced increases in W/D, PCBAL, MDA level, and MMP-9 activity in the right lung. SOD treatment during the first hour of a 5-hour reperfusion protected the lung through suppressing MMP-9 activity and reducing tissue lipid peroxidation.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26036525     DOI: 10.1016/j.transproceed.2014.10.060

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Baicalin ameliorates lipopolysaccharide-induced acute lung injury in mice by suppressing oxidative stress and inflammation via the activation of the Nrf2-mediated HO-1 signaling pathway.

Authors:  Xiangli Meng; Lin Hu; Wenqiang Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-04       Impact factor: 3.000

2.  Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model.

Authors:  Eliza W Beal; Curtis Dumond; Jung-Lye Kim; Khalid Mumtaz; Don Hayes; Ken Washburn; Bryan A Whitson; Sylvester M Black
Journal:  J Vis Exp       Date:  2017-04-02       Impact factor: 1.355

3.  Maresin 1 Ameliorates Lung Ischemia/Reperfusion Injury by Suppressing Oxidative Stress via Activation of the Nrf-2-Mediated HO-1 Signaling Pathway.

Authors:  Quanchao Sun; You Wu; Feng Zhao; Jianjun Wang
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

4.  Does methylene blue attenuate inflammation in nonischemic lungs after lung transplantation?

Authors:  Marcus da Matta Abreu; Francine Maria de Almeida; Kelli Borges Dos Santos; Emílio Augusto Campos Pereira de Assis; Rafael Kenji Fonseca Hamada; Fabio Biscegli Jatene; Paulo Manuel Pêgo-Fernandes; Rogerio Pazetti
Journal:  J Bras Pneumol       Date:  2018 Sep-Oct       Impact factor: 2.624

5.  The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion-induced lung injury.

Authors:  Lei Wang; Yanling Ding; Yanhui Bai; Jian Shi; Jia Li; Xiuli Wang
Journal:  Ann Transl Med       Date:  2022-03

6.  Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway.

Authors:  Lin Fei; Xiao Jingyuan; Liang Fangte; Dai Huijun; Ye Liu; Jing Ren; Lin Jinyuan; Pan Linghui
Journal:  J Transl Med       Date:  2020-08-05       Impact factor: 5.531

Review 7.  Superoxide Dismutase Administration: A Review of Proposed Human Uses.

Authors:  Arianna Carolina Rosa; Daniele Corsi; Niccolò Cavi; Natascia Bruni; Franco Dosio
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.